首页> 外国专利> Hybrid cells for human interferon antibodies - prepd. by fusing myeloma cells with mouse anti:interferon cells

Hybrid cells for human interferon antibodies - prepd. by fusing myeloma cells with mouse anti:interferon cells

机译:人干扰素抗体的杂交细胞-制备通过将骨髓瘤细胞与小鼠抗干扰素细胞融合

摘要

Hybrid cells capable of producing human interferon antibodies are prepd. by fusion of myeloma cells, and the like, with cells producing human anti-interferon antibodies, originally coming from a host animal, such as a mouse. These hybrid cells have the characteristic of inducing liq. tumours, notably ascites, when implanted in vivo. Purificn. of interferon used in therapy, and measurement of interferon in experimental and clinical pharmacology.
机译:准备能够产生人干扰素抗体的杂交细胞。通过使骨髓瘤细胞等与产生人抗干扰素抗体的细胞融合,所述细胞最初来自宿主动物,例如小鼠。这些杂种细胞具有诱导液的特性。当植入体内时,肿瘤尤其是腹水。净化。用于治疗的干扰素的测定,以及实验和临床药理学中干扰素的测定。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号